CureVac Announces Pricing of $450 million Follow-on Public Offering of Common Shares
Accesswire
*TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 28, 2021 /* CureVac N.V. (Nasdaq: CVAC) ("CureVac" or the "Company"), a..
Gov. Sisolak give COVID-19 update and vaccine information
Credit: KTNV Channel 13 Las Vegas
Duration: 25:32s
0 shares
2 views
Advertisement
Related news coverage
-
Abcam Plc Appointment of Non-Executive Directors
GlobeNewswire
-
Valneva Commences Manufacturing of its Inactivated, Adjuvanted COVID-19 Vaccine, Completes Phase 1/2 Study Recruitment
GlobeNewswire
-
Methanex Reports Higher Fourth Quarter 2020 Results
GlobeNewswire
-
Salisbury Bancorp, Inc. Reports Record Full Year 2020 Results; Declares 29 Cent Dividend
GlobeNewswire
You might like
More coverage
Petroteq Energy Announces That Production of Oil From Its Oil Sands Plant Has Recommenced
Accesswire
· *Optimization and Fine Tuning of Plant Systems For Continuous Operation Is Underway While the Plant Is Being Commissioned..
-
TOMI Environmental Completes Study With University of Virginia Demonstrating Its Disinfection Unit Achieves Kill on SARS CoV-2 Virus in 5 Seconds
GlobeNewswire
-
Vaxart Announces Publication of a Peer-reviewed Journal Article Showing the Potential Clinical and Economic Value of a Norovirus Vaccine
GlobeNewswire
-
Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Waldenstrom’s Macroglobulinemia
GlobeNewswire
-
Nasdaq Grants Guardion Health Sciences an Extension to March 15, 2021 to Regain Compliance with the $1.00 Minimum Bid Price Rule
GlobeNewswire